MIRUM PHARMACEUTICALS ($MIRM) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of -$0.39 per share, missing estimates of -$0.36 by $0.03. The company also reported revenue of $159,880,000, beating estimates of $152,525,363 by $7,354,637.
You can see Quiver Quantitative's $MIRM stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MIRUM PHARMACEUTICALS Insider Trading Activity
MIRUM PHARMACEUTICALS insiders have traded $MIRM stock on the open market 29 times in the past 6 months. Of those trades, 1 have been purchases and 28 have been sales.
Here’s a breakdown of recent trading of $MIRM stock by insiders over the last 6 months:
- MICHAEL G GREY has made 0 purchases and 3 sales selling 150,000 shares for an estimated $11,100,000.
- PATRICK J HERON purchased 131,425 shares for an estimated $8,999,984
- CHRISTOPHER PEETZ (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 4 sales selling 64,022 shares for an estimated $6,030,112.
- PETER RADOVICH (PRESIDENT AND COO) has made 0 purchases and 4 sales selling 24,671 shares for an estimated $2,315,438.
- JOANNE QUAN (CHIEF MEDICAL OFFICER) has made 0 purchases and 3 sales selling 16,020 shares for an estimated $1,464,134.
- SAIRA RAMASASTRY has made 0 purchases and 7 sales selling 15,000 shares for an estimated $1,300,940.
- ERIC BJERKHOLT (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 9,761 shares for an estimated $904,148.
- JOLANDA HOWE (SVP, GLOBAL CONTROLLER) has made 0 purchases and 4 sales selling 7,468 shares for an estimated $702,650.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
MIRUM PHARMACEUTICALS Hedge Fund Activity
We have seen 156 institutional investors add shares of MIRUM PHARMACEUTICALS stock to their portfolio, and 133 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 1,067,722 shares (+21.4%) to their portfolio in Q4 2025, for an estimated $84,339,360
- STATE STREET CORP added 797,088 shares (+59.2%) to their portfolio in Q4 2025, for an estimated $62,961,981
- POINT72 ASSET MANAGEMENT, L.P. removed 600,037 shares (-75.9%) from their portfolio in Q4 2025, for an estimated $47,396,922
- WELLINGTON MANAGEMENT GROUP LLP added 447,141 shares (+56.6%) to their portfolio in Q4 2025, for an estimated $35,319,667
- EVENTIDE ASSET MANAGEMENT, LLC removed 428,981 shares (-17.0%) from their portfolio in Q4 2025, for an estimated $33,885,209
- SOLEUS CAPITAL MANAGEMENT, L.P. added 424,918 shares (+285.8%) to their portfolio in Q4 2025, for an estimated $33,564,272
- MACQUARIE GROUP LTD removed 393,212 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $31,059,815
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
MIRUM PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $MIRM recently. We have seen 10 analysts offer price targets for $MIRM in the last 6 months, with a median target of $127.0.
Here are some recent targets:
- Michael Ulz from Morgan Stanley set a target price of $140.0 on 05/05/2026
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $175.0 on 05/04/2026
- James Condulis from Stifel set a target price of $130.0 on 04/29/2026
- Brian Skorney from Baird set a target price of $112.0 on 04/28/2026
- Jonathan Wolleben from Citizens set a target price of $132.0 on 04/21/2026
- Joseph Thome from TD Cowen set a target price of $125.0 on 03/27/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $126.0 on 03/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
